Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pale Blue Dot in connection with fund establishment
Mandate

Vinge has advised Pale Blue Dot in connection with fund establishment

June 24, 2020 Capital Markets and Public M&A

Vinge has advised Pale Blue Dot in connection with the structuring, fund raising and establishment of Pale Blue Dot’s first fund.

The fund conducted its first close in June 2020 in the amount of EUR 53 million. Pale Blue Dot is a Swedish venture capital fund focusing on early investments in European climate technology companies.

Vinge’s team primarily consisted of Rickard Vernet, Jesper Ottergren, Joel Wennerholm, Martin Svanberg, as well as Mattias Schömer (Tax) and Viveka Claesson (Regulatory Issues).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026